Navigation Links
Hoag Breast Care Center First in California to Offer 3D Mammography
Date:9/21/2011

NEWPORT BEACH, Calif., Sept. 21, 2011 /PRNewswire/ -- Hoag Memorial Hospital Presbyterian announced today that Hoag Breast Care Center is the first breast care center in California and one of only a handful in the United States to offer 3D digital breast tomosynthesis for breast cancer screening. This revolutionary technology promises to improve breast cancer detection, especially in young women and women of any age with radiographically dense breast tissue. Women who undergo routine mammograms at Hoag Breast Care Center now have the latest screening technology available to them.

Digital breast tomosynthesis (DBT) is an FDA-approved 3D imaging modality that gives radiologists the ability to identify and characterize individual breast structures without the confusion of overlapping tissue, the Achilles heel of 2D digital mammography.  Breast tomosynthesis is especially beneficial for women with dense breasts. Dense breast tissue can obscure an underlying cancer, or conversely mimic a cancer when none exists. Approximately 15 to 20 percent of breast cancers cannot be detected using traditional 2D mammography, especially in women with dense breast tissue.

"It's a major milestone to be the first breast center in California to provide patients with digital breast tomosynthesis," said Gary M. Levine, M.D., director of breast imaging at Hoag Breast Care Center and one of the nation's leading experts in breast tomosynthesis. "At Hoag we have been involved with the development and testing of tomosynthesis since 2009. Recent reader studies have confirmed digital breast tomosynthesis to be superior to conventional mammography alone at finding early breast cancer. Tomosynthesis will allow us to discover more early stage breast cancers, and early detection translates to lives saved."

During a tomosynthesis exam, 15 digital "projection" images are captured as it arcs over the breast, during a short four-second scan. These images are then digitally reconstructed into a series of high-resolution one-millimeter slices that can be reviewed individually or played back in a cine loop.

"Tomosynthesis, by solving the issue of tissue superimposition, will not only allow us to detect breast cancer more reliably, it will also reduce the number of unnecessary call backs for additional testing," adds Dr. Levine. "This will then address a frequent criticism of mammography by reducing anxiety and controlling costs."

A woman can learn if her breasts are dense by asking her physician or the radiologist who performs her mammogram. Breast density is not based on family history and cannot be determined by look and feel of the breast. Approximately 75 percent of women in their forties have dense breasts, and this percentage typically decreases with age – with 54 percent of women in their fifties and 42 percent of women in their sixties having dense breasts.(i) Approximately 40 to 50 percent of women Hoag screens annually have extremely dense breast tissue, particularly younger women ages 40-49.

Regardless of whether a woman has dense breast tissue or not, mammograms and self breast awareness play a crucial role in early detection. Breast cancer is the second leading cause of cancer death among women, exceeded only by lung cancer. Statistics indicate that one in eight women will develop breast cancer sometime in her lifetime. The stage at which breast cancer is detected influences a woman's chance of survival. If found and treated early, while still localized in the breast, the ten-year survival rate for breast cancer is greater than 90 percent.

Hoag is pleased to offer digital breast tomosynthesis to Orange County women due to a generous grant from Circle 1000, a dedicated group of women that have raised funds for Hoag Family Cancer Institute since 1987. In the near future, Hoag will be extending this technology to Irvine as well.

Hoag is committed to the fight against breast cancer. In offering 3D breast tomosynthesis digital mammography, Hoag Breast Care Center provides the latest in imaging quality and the specialized experts to ensure the highest quality of care for patients.

For more information including video, images and a media kit, visit http://Hoag.porternovelli.com/.

About Hoag Memorial Hospital Presbyterian

Hoag is a not-for-profit regional healthcare delivery network in Orange County, Calif. that treats nearly 30,000 inpatients and 350,000 outpatients annually. Hoag consists of two acute-care hospitals, seven health centers and three urgent care centers (with two more scheduled to open in Fall 2011). Hoag Hospital Newport Beach, which has served Orange County since 1952, and Hoag Hospital Irvine, which opened in 2010, are designated Magnet hospitals by the American Nurses Credentialing Center (ANCC). Hoag offers a comprehensive blend of health care services that include five institutes providing specialized services in the following areas: cancer, heart and vascular, neurosciences, women's health and orthopedics through Hoag's affiliate Hoag Orthopedic Institute. Hoag has been named one of the Best Regional Hospitals in the U.S. News & World Report Metro Edition. National Research Corporation has endorsed Hoag as Orange County's most preferred hospital for the past 15 consecutive years and for an unprecedented 15 years, residents of Orange County have chosen Hoag as the county's best hospital in a local newspaper survey. Visit www.hoag.org.

(i) According to findings at the 10th Annual Meeting of the American Society of Breast Surgeons

Media Contacts:
Paula Moggio
Paula.Moggio@porternovelli.com
323-762-2434

Andrea Burgess
Andrea.Burgess@hoag.org
949-764-6939


'/>"/>
SOURCE Hoag Memorial Hospital Presbyterian
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
3. Xeloda(R) XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
4. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
5. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
6. Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer
7. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
8. New Study Demonstrates 4 Year Olds Fed Enfamil LIPIL(R) as Infants Have Brain and Eye Outcomes Similar to Breastfed Babies
9. Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
10. Spit for the Cure Offers Unique Opportunity for Women to Participate in Breast Cancer Research
11. Genomic Health Announces Preliminary Results From a Study of Oncotype DX(TM) in Node-Positive Breast Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... LONDON , January 20, 2017 Avillion ... the appointment of Mark Weinberg , MD MBA as Chief ... , USA . ... Dr Weinberg has spent more than 17 ... "top 20" pharma companies to micro-cap biotech. Over the course of ...
(Date:1/19/2017)... 2017 Report Details What can ... are going to grow at the fastest rates? This ... data, trends, opportunities and prospects. Our 190-page report ... lucrative areas in the industry and the future market ... across the all the major categories of the ophthalmic ...
(Date:1/19/2017)... Conference Call and Webcast to Follow Vanda ... will release results for the fourth quarter of 2016 on Wednesday, ... ... at 4:30 PM ET on Wednesday, February 15, 2017, during which ... results and other corporate activities. To participate in the conference call, ...
Breaking Medicine Technology:
(Date:1/21/2017)... ... , ... In the United States, 20 million women and 10 million men ... feel shame for having struggled with an eating disorder as well as common co-occurring ... in Life After an Eating Disorder” -- to be featured at this year’s iaedp ...
(Date:1/20/2017)... ... 2017 , ... Source Vitál Apothecary, a skin and body care company dedicated ... company had a successful visit to the 2017 ECRM Diet, Vitamin & Sports Nutrition ... in the nutritional, sports and health industries a chance to meet in private sessions ...
(Date:1/20/2017)... ... January 20, 2017 , ... International Protein, a company based out of Australia ... attended the January ECRM trade show in Hilton Head, SC. , International Protein ... to create a line of products that would elevate her fitness regime. At this ...
(Date:1/20/2017)... ... January 20, 2017 , ... “The Angel”: a heartwarming and earnest ... for each of his children. “The Angel” is the creation of published author, Marjorie ... York City, and impassioned writer. , When asked of her new book, Marjorie says, ...
(Date:1/20/2017)... ... , ... “Journey to Christmas:” a beautiful and enchanting tale that teaches children the true meaning ... of three in Oklahoma City, and a devoted woman of faith. , “Becoming a ... in the back of my mind for years, but actually doing it might have been ...
Breaking Medicine News(10 mins):